(Q36669469)

15 August 2017

1 reference

title

Current perspectives on management of co-morbid depression in COPD. (English)

1 reference

15 August 2017

Rachel Norwood

1

1 reference

15 August 2017

Ronald Balkissoon

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

COPD: Journal of Chronic Obstructive Pulmonary Disease

15 August 2017

published in

1 reference

15 August 2017

volume

2

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

185-193

1 reference

Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

The relationship between mental disorders and physical severities in patients with acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Symptomatic depression in elderly medical outpatients. I. Prevalence, demography, and health service utilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

The Poorly Coping COPD Patient: A Psychotherapeutic Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Psychosocial concomitants to rehabilitation in chronic obstructive pulmonary disease. Part I. Psychosocial and psychological considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Is smoking associated with depression and anxiety in teenagers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Nicotine dependence and major depression. New evidence from a prospective investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Cigarette smoking and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Tobacco cessation among patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Major depression following smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Brain monoamine oxidase A inhibition in cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

White matter hyperintensity signals in psychiatric and nonpsychiatric subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

MRI and neuropsychological differences in early- and late-life-onset geriatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Functional impairment in COPD patients: the impact of anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Griseofulvin and fluvoxamine interactions with the metabolism of theophylline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Fluoxetine (Prozac) as a cause of QT prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

QTc interval prolongation associated with citalopram overdose: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

Psychiatric disorder in a sample of the general population with and without chronic medical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050740

21 January 2018

Identifiers

DOI

10.1081/COPD-200050740

1 reference

15 August 2017

1 reference